“The principal villain in rising health care costs is the government. Not pharmaceutical companies, not doctors, but government.” GovernmentCareCompanyCostDoctorsHealth CareRisingVillainPrincipalPharmaceuticalPharmaceutical CompaniesHealth Care Costs Author:Neal Boortz
“Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even more complex and expensive. Simple economics dictates that companies and venture funds will invest more in products that can generate a sufficient return.” SimpleCompanyProductsReturnCostDrugEconomicsDollarsComplexesBillionsTraditionalSufficientExpensiveFundVenturePharmaceuticalTailored Author:David Mixner
“Pharmaceutical companies have invested hundreds of millions of dollars in new HIV/AIDS treatments not out of altruism but because they can make up those research costs in sales.” CompanyMillionsCostResearchDollarsAidsTreatmentAltruismHivPharmaceuticalHiv AidsPharmaceutical Companies Author:David Mixner
“They're [[harmaceuticals companies] just making a killing out of people's death. And they're benefiting by people's suffering. And I find that obscene. I find it ridiculous in this day and age, that that would happen. And it took President Clinton to go to rogue pharmaceutical companies to copy the antiretroviral drugs for a fraction of the cost.” PeopleHappensAgeSufferingPresidentCompanyCostDrugClintonKillingRidiculousCopiesThis DayFractionsRoguesObscenePharmaceuticalPresident ClintonPharmaceutical Companies Author:Elton John
“In a large pharmaceutical company, where it's a big bet, you're going to need finance people to be involved in the decision-making because the investment can run into the hundreds of millions of dollars. You're going to have to run scenarios. You might even need agreement from the C.E.O. to make that type of decision. If it's an incremental, low-cost decision in a marketing-oriented company, it may be a very different set of stakeholders a lot further down in the organization.” PeopleIfsNeedsMayDifferentBigsMightRunningDecisionCompanyMillionsTypeInvolvedCostLowsOrganizationDollarsInvestmentMarketingFinanceAgreementDecision MakingScenariosPharmaceuticalStakeholderPharmaceutical Companies Author:John Kao
“You can think of the Health Impact Fund as a mechanism that would keep the benefits and burdens of pharmaceutical innovation for the affluent roughly as they are while massively reducing the burdens presently imposed upon the poor. This sounds like magic. But it really works because the current system is not Pareto efficient. It's a system that generates hundreds of billions of dollars in litigation costs and deadweight losses that HIF-registered medicines would sidestep. By avoiding these losses, the HIF reform can bring improvements all around - including for pharmaceutical innovators.” ThinkingSoundLossPoorMagicCostBenefitsInnovationImpactDollarsMedicineIncludingCurrentsBurdenBillionsImprovementReformFundMechanismEfficientAvoidingWeight LossReducingInnovatorsAffluentPharmaceutical Author:Thomas Pogge
“We cannot rest until we make sure that our families can afford to live and raise their kids here, that our seniors can remain in their homes and afford their health and pharmaceutical costs.” HomeKidsCostRaisesOur FamilySeniorPharmaceutical Author:Carl Lewis
“While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.” ValuesNationsSupportFocusDevelopmentCostDrugResearchImportanceWealthySeniorPrescriptionsPharmaceuticalResearch And DevelopmentPrescription DrugsGreat Value Author:Michael K. Simpson